ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Fruzaqla 5 mg, Hartkapseln - 21
69524002 Takeda Pharma AG
Fruzaqla 5 mg, Hartkapseln27.08.2024
  27.08.2024
(L01EK04) 
WHO-DDD26.08.2029
07.16.10.21
07.16.10. 
A  
Yes 
IP 
3782.91Yes
    
10 %4130.55
  
7680695240023Synthetika
  
Composition
fruquintinibum 5 mg, maydis amylum, cellulosum microcristallinum, talcum, Kapselhülle: gelatina, E 171, E 133, E 129 0.1829 mg, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Fruquintinibum5 mg
BAG: Active AgentDose
Fruquintinibum5 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Cellulosum Microcristallinum  
E 1290.1829 mgcolor.
E 133 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Maydis Amylum  
Pro Capsula  
Propylenglycol  
Talcum  
 
Source
Data was imported : 05.09.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home